These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24523042)

  • 1. Identification of underserved areas for urologic cancer care.
    Mossanen M; Izard J; Wright JL; Harper JD; Porter MP; Daratha KB; Holt SK; Gore JL
    Cancer; 2014 May; 120(10):1565-71. PubMed ID: 24523042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race and postoperative complications following urologic cancer surgery: An ACS-NSQIP analysis.
    Parker DC; Handorf E; Smaldone MC; Uzzo RG; Pitt H; Reese AC
    Urol Oncol; 2017 Dec; 35(12):670.e1-670.e6. PubMed ID: 28867431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readmissions after major urologic cancer surgery.
    Leow JJ; Gandaglia G; Sood A; Ruhotina N; Klett DE; Sammon JD; Schmid M; Sun M; Chang SL; Kibel AS; Trinh QD
    Can J Urol; 2014 Dec; 21(6):7537-46. PubMed ID: 25483761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inequity in selective referral to high-volume hospitals for genitourinary malignancies.
    Berg S; Tully KH; Sahraoui A; Tan WS; Krimphove MJ; Marchese M; Lipsitz SR; Noldus J; Trinh QD
    Urol Oncol; 2020 Jun; 38(6):582-589. PubMed ID: 32217041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of hospital readmissions after urologic cancer surgery.
    Schmid M; Chiang HA; Sood A; Campbell L; Chun FK; Dalela D; Okwara J; Sammon JD; Kibel AS; Menon M; Fisch M; Trinh QD
    Urol Oncol; 2016 May; 34(5):236.e1-11. PubMed ID: 26712365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in access to care at high-volume institutions for uro-oncologic procedures.
    Trinh QD; Sun M; Sammon J; Bianchi M; Sukumar S; Ghani KR; Jeong W; Dabaja A; Shariat SF; Perrotte P; Agarwal PK; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
    Cancer; 2012 Sep; 118(18):4421-6. PubMed ID: 22298310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond classic risk adjustment: Socioeconomic status and hospital performance in urologic oncology surgery.
    Odisho AY; Etzioni R; Gore JL
    Cancer; 2018 Aug; 124(16):3372-3380. PubMed ID: 29905929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Disparities in Surgical Outcomes Among Males Following Major Urologic Cancer Surgery.
    Sathianathen NJ; Jarosek SL; Fan Y; Krishna SR; Konety BR
    Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S14-S21. PubMed ID: 30670197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episode-based Payment Variation for Urologic Cancer Surgery.
    Ellimoottil C; Li J; Ye Z; Dupree JM; Min HS; Kaye D; Herrel LA; Miller DC
    Urology; 2018 Jan; 111():78-85. PubMed ID: 29051001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital-level variation in the quality of urologic cancer surgery.
    Gore JL; Wright JL; Daratha KB; Roberts KP; Lin DW; Wessells H; Porter M
    Cancer; 2012 Feb; 118(4):987-96. PubMed ID: 21792864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient experience and quality of urologic cancer surgery in US hospitals.
    Shirk JD; Tan HJ; Hu JC; Saigal CS; Litwin MS
    Cancer; 2016 Aug; 122(16):2571-8. PubMed ID: 27254231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better?
    Konety BR; Allareddy V; Modak S; Smith B
    J Clin Oncol; 2006 May; 24(13):2006-12. PubMed ID: 16648501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United States.
    Mazzone E; Mistretta FA; Knipper S; Tian Z; Larcher A; Widmer H; Zorn K; Capitanio U; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    J Endourol; 2019 Jun; 33(6):438-447. PubMed ID: 30931607
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of hospital provider volume on outcome for radical urological cancer surgery in England.
    Hanchanale VS; Javlé P
    Urol Int; 2010; 85(1):11-5. PubMed ID: 20616525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teaching Hospitals and Textbook Outcomes After Major Urologic Cancer Surgery.
    Dall CP; Liu X; Faraj KS; Srivastava A; Kaufman SR; Shahinian VB; Hollenbeck BK
    Urology; 2024 Sep; 191():64-70. PubMed ID: 38878826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Urologic Cancer Surgical Volume and Length of Stay During the COVID-19 Pandemic in Pennsylvania.
    Chun B; Ramian H; Jones C; Vasan R; Yabes JG; Davies BJ; Sabik LM; Jacobs BL
    JAMA Netw Open; 2023 Apr; 6(4):e239848. PubMed ID: 37097635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do hospital service areas and hospital referral regions define discrete health care populations?
    Kilaru AS; Wiebe DJ; Karp DN; Love J; Kallan MJ; Carr BG
    Med Care; 2015 Jun; 53(6):510-6. PubMed ID: 25961661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering better care and value in urological procedures.
    Leow JJ; Trinh QD
    Can J Urol; 2015 Aug; 22(4):7857. PubMed ID: 26267022
    [No Abstract]   [Full Text] [Related]  

  • 19. Regionalization of radical cystectomy in the United States.
    Anderson CB; Gennarelli R; Herr HW; Elkin EB
    Urol Oncol; 2017 Aug; 35(8):528.e7-528.e13. PubMed ID: 28412027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the quality of the volume-outcome relationship in uro-oncology.
    Mayer EK; Purkayastha S; Athanasiou T; Darzi A; Vale JA
    BJU Int; 2009 Feb; 103(3):341-9. PubMed ID: 18990134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.